LGALS1/Galectin 1 Antikörper
-
- Target Alle LGALS1/Galectin 1 (LGALS1) Antikörper anzeigen
- LGALS1/Galectin 1 (LGALS1) (Lectin, Galactoside-Binding, Soluble, 1 (LGALS1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LGALS1/Galectin 1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Whole Mount) (IHC (wm))
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
-
Rabbit Polyclonal antibody to Galectin 1 (lectin, galactoside-binding, soluble, 1)
Galectin 1 antibody - Aufreinigung
- Purified by antigen-affinity chromatography.
- Güteklasse
- KO Validated
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human Galectin 1. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product LGALS1 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:5000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IHC-Fr: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: NCI-H929 , BCL-1 , PC-12 , Rat2 , HeLa
Validation: KO/KD, Orthogonal
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.52 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics." in: Frontiers in immunology, Vol. 11, pp. 1316, (2020) (PubMed).
: "Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008." in: Journal of experimental & clinical cancer research : CR, Vol. 37, Issue 1, pp. 67, (2019) (PubMed).
: "
-
Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics." in: Frontiers in immunology, Vol. 11, pp. 1316, (2020) (PubMed).
-
- Target
- LGALS1/Galectin 1 (LGALS1) (Lectin, Galactoside-Binding, Soluble, 1 (LGALS1))
- Andere Bezeichnung
- galectin 1 (LGALS1 Produkte)
- Synonyme
- GAL1 antikoerper, GBP antikoerper, Galectin-1 antikoerper, LGAS1 antikoerper, LGALS1 antikoerper, MGC64502 antikoerper, GB10026 antikoerper, AA410090 antikoerper, Gal-1 antikoerper, Galbp antikoerper, L-14.5 antikoerper, L14 antikoerper, Lect14 antikoerper, galectin-1 antikoerper, Galaptin antikoerper, galectin 1 antikoerper, galectin-1 antikoerper, lectin, galactoside-binding, soluble, 1 L homeolog antikoerper, protein enabled antikoerper, lectin, galactose binding, soluble 1 antikoerper, LGALS1 antikoerper, Lgals1 antikoerper, CC1G_05003 antikoerper, CC1G_05004 antikoerper, lgals1.L antikoerper, LOC408848 antikoerper
- Hintergrund
-
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. This gene product may act as an autocrine negative growth factor that regulates cell proliferation.
Cellular Localization: Secreted , extracellular space , extracellular matrix - Molekulargewicht
- 15 kDa
- Gen-ID
- 3956
- UniProt
- P09382
- Pathways
- Carbohydrate Homeostasis
-